Showing 441-450 of 1066 results for "".
Stroke Snapshot: Reversible Cerebral Vasoconstriction Syndrome
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-reversible-cerebral-vasoconstriction-syndrome/31820/Early correct diagnosis is imperative because RCVS presentations can overlap with diverse syndromes with disparate treatments.Medical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.Advance Care Planning in Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/advance-care-planning-in-amyotrophic-lateral-sclerosis/31809/Focusing on feelings, facts, and family is useful in shared decision making.An Update on Nutraceuticals for Migraine Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-nutraceuticals-for-migraine-management/32132/Many people with migraine use integrative modalities, including nutraceutical supplements, along with mainstream medicine for disease control.Neuromuscular Amyloidosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-amyloidosis/31815/The most common amyloidosis are both treatable; accurate diagnosis is paramount.Selection and Interpretation of Biomarker Tests for Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/selection-and-interpretation-of-biomarker-tests-for-alzheimer-disease/36191/Diagnostic tests for Alzheimer disease can help guide clinical management, but results must be interpreted carefully.A Practical Approach to Selecting Patients for Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/a-practical-approach-to-selecting-patients-for-amyloid-targeting-treatments/36190/A review of the clinical criteria, key challenges, and future directions in selecting patients for amyloid-targeting treatments.- How Will Genomics Affect the Practice of Neurology?https://practicalneurology.com/columns/practice-management/how-will-genomics-affect-the-practice-of-neurology/31116/Genomics is increasingly revolutionizing the field of neurology, transforming both the understanding and treatment of neurological disorders. Since the completion of the human genome mapping in 2003, advancements in structural and functional genomics have provided deep insights into gene sequences,
- Pregnancy Prevention in Epilepsy: Assessing the Optionshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0206PregnancyEpilepsy-pdf/31346/Epilepsy significantly affects the quality of life for women, particularly in areas of professional, academic, and social functioning. For women of childbearing age, managing epilepsy intersects critically with family planning and reproductive health decisions. However, there is a notable gap in the
Frontotemporal Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/frontotemporal-dementias/31537/Careful clinical, neuropsychologic, and imaging investigations make differential diagnosis of variants possible.